BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14006235)

  • 1. Neutralization of "long-acting thyroid stimulator" of Graves' disease by antisera to bovine pituitary thyrotropin.
    WERNER SC; TIERNEY J
    Proc Soc Exp Biol Med; 1961 Dec; 108():780-4. PubMed ID: 14006235
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
    Lamberg BA; Gordin A
    Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of iodine administration on the thyrotropic hormone and long-acting thyroid stimulator level in the plasma].
    Földes J; Krasznai I; Piroska E; Gesztesi E; Takács I
    Endokrinologie; 1967; 52(1):80-7. PubMed ID: 4171706
    [No Abstract]   [Full Text] [Related]  

  • 4. The long-acting thyroid stimulator.
    Munro DS
    Curr Top Exp Endocrinol; 1971; 1():175-98. PubMed ID: 4350824
    [No Abstract]   [Full Text] [Related]  

  • 5. ["ABNORMAL THYROID STIMULATOR" FROM THE PITUITARY IN HYPERPARATHYROIDISM].
    KUMAHARA Y; MIYAI K; SAKAGAMI A; FUKUCHI M; MASUI H; IWATSUBO H
    Nihon Naika Gakkai Zasshi; 1964 Apr; 53():66-70. PubMed ID: 14181629
    [No Abstract]   [Full Text] [Related]  

  • 6. IMMUNOLOGICAL STUDIES ON THE LONG-ACTING THYROID STIMULATOR.
    DORRINGTON KJ; MUNRO DS
    Clin Sci; 1965 Feb; 28():165-74. PubMed ID: 14256898
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanisms of Graves' disease and endocrine exophthalmos.
    Anderson DR
    Am J Ophthalmol; 1969 Jul; 68(1):46-57. PubMed ID: 4895778
    [No Abstract]   [Full Text] [Related]  

  • 8. On the effect of thyrotropin and immunoglobulins related to Graves' disease on thyrotropin synthesis and secretion.
    Dandona P; El Kabir DJ
    Clin Endocrinol (Oxf); 1978 Oct; 9(4):321-7. PubMed ID: 581481
    [No Abstract]   [Full Text] [Related]  

  • 9. Does LATS cause hyperthyroidism in Graves' disease? (A review biased toward the affirmative).
    McKenzie JM
    Metabolism; 1972 Sep; 21(9):883-94. PubMed ID: 4115791
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biological determination of thyrotropin and long-acting thyroid simulator].
    Potin VV; Stepanov GS
    Probl Endokrinol (Mosk); 1969; 15(4):64-7. PubMed ID: 5395630
    [No Abstract]   [Full Text] [Related]  

  • 11. Neutralization of human thyrotropin by antisera to subunits of glycoprotein hormones.
    Nisula BC; Kohler PO; Vaitukaitis JL; Hershman JM; Ross GT
    J Clin Endocrinol Metab; 1973 Nov; 37(5):664-9. PubMed ID: 4127180
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosis of Graves' ophthalmopathy without hyperthyroidism: long-acting thyroid stimulator (LATS) determination as laboratory adjunct.
    Gharib H; Mayberry WE
    Mayo Clin Proc; 1970 Jun; 45(6):444-9. PubMed ID: 4193249
    [No Abstract]   [Full Text] [Related]  

  • 13. ["Long-acting thyroid stimulator" and thyrotropic hormone in thyrotoxicosis in newborn infants].
    Gautier E; Juillard E; Lemarchand-Béraud T
    Schweiz Med Wochenschr; 1968 Jan; 98(1):8-12. PubMed ID: 5695264
    [No Abstract]   [Full Text] [Related]  

  • 14. Failure of TSH antisera to neutralize long-acting thyroid stimulator.
    ADAMS DD; KENNEDY TH; PURVES HD; SIRET NE
    Endocrinology; 1962 Jun; 70():801-5. PubMed ID: 13859304
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation of long-acting thyroid stimulator with serum levels of tri-iodothyronine, thyroxine and thyrotropin in Graves' disease.
    Sawhney RC; Kannan V; Rastogi GK
    J Assoc Physicians India; 1975 Feb; 23(2):111-4. PubMed ID: 1242389
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the pathogenesis of the ophthalmopathy of Graves' disease.
    Kriss JP; Pleshakov V; Rosenblum AL; Holderness M; Sharp G; Utiger R
    J Clin Endocrinol Metab; 1967 Apr; 27(4):582-93. PubMed ID: 6071430
    [No Abstract]   [Full Text] [Related]  

  • 17. Thyrotropin-producing pituitary adenoma simultaneously existing with Graves' disease: a case report.
    Arai N; Inaba M; Ichijyo T; Kagami H; Mine Y
    J Med Case Rep; 2017 Jan; 11(1):9. PubMed ID: 28061802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities of hypothalamo-hypophyseal-thyroid axis in patients with Graves' ophthalmopathy.
    Chopra IJ; Chopra U; Orgiazzi J
    J Clin Endocrinol Metab; 1973 Dec; 37(6):955-67. PubMed ID: 4201831
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical and hormonal development of a case of malignant exophthalmus after hypophyseal myskiotomy].
    Stoica T; Arseni C; Constantinescu A; Coculescu M; Balmeş E
    Endocrinologie; 1977; 15(4):283-8. PubMed ID: 579476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vitro procedure for the estimation of thyroid hormone releasing factors in sera of thyrotoxic patients.
    Maayan ML; Volpert EM; Dawry FP
    J Endocrinol Invest; 1978 Oct; 1(4):299-304. PubMed ID: 92490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.